Log In
Print
BCIQ
Print
Print this Print this
 

Glybera, alipogene tiparvovec (AMT-011) (formerly AMT-010)

Also known as: AAV vector encoding lipoprotein lipase (LPL) gene

  Manage Alerts
Collapse Summary General Information
Company uniQure N.V.
DescriptionAdeno-associated virus (AAV) vector carrying lipoprotein lipase (LPL) gene
Molecular Target Not available
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentApproved
Standard IndicationHypertriglyceridemia
Indication DetailsTreat lipoprotein lipase deficiency (LPLD)
Regulatory Designation

U.S. - Orphan Drug (Treat lipoprotein lipase deficiency (LPLD));
EU - Orphan Drug (Treat lipoprotein lipase deficiency (LPLD))

Partner

Chiesi Farmaceutici S.p.A.; Medison Pharma Ltd.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$40.3M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today